[Federal Register Volume 66, Number 207 (Thursday, October 25, 2001)]
[Notices]
[Page 54033]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-26878]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice date December 21, 2000, and published in the Federal 
Register on January 10, 2001, (66 FR 2005), Orpharm, Inc., 4815 Dacoma, 
Houston, Texas 77092, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methylphenidate (1724)......................  II
Methadone (9250)............................  II
Methadone-intermediate (9254)...............  II
levo-alphacetylmethadol (9648)..............  II
------------------------------------------------------------------------

    The firm plans to bulk manufacture the listed controlled substances 
for formulation into finished pharmaceuticals.
    No comments or objections have been received. DEA has considered 
the factors, in title 21, United States Code, Section 823(a) and 
determined that the registration of Orpharm, Inc. to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Orpharm, Inc. on a regular basis to 
ensure that the company's continued registration is consistent with the 
public interest. These investigations have included inspection and 
testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed above is granted.

    Dated: October 12, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-26878 Filed 10-24-01; 8:45 am]
BILLING CODE 4410-09-M